Cibus, Inc. (CBUS) vs Health Catalyst, Inc. (HCAT)

A side-by-side comparison of Cibus, Inc. and Health Catalyst, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CBUS vs HCAT

growth of $100 · dividends reinvested · last 7y
CBUS -99.6% (-55.2%/yr)HCAT -95.5% (-35.8%/yr)HCAT compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $100202120232025$0$4
CBUS HCAT

CBUS vs HCAT: by the numbers

  • •HCAT is the larger company ($130M vs $124M market cap).
  • •Both run net losses; HCAT's is the smaller (-90.61% vs -2258.89% net margin).
  • •HCAT grew revenue faster over the past five years (6.24% vs -34.28% CAGR).

Metrics side by side

Valuation

MetricCBUSHCAT
P/S ratio28.450.44
P/B ratio8.351.29
EV / EBITDAN/A74.04
FCF yieldN/A10.07%

Profitability

MetricCBUSHCAT
Gross margin-62.76%33.47%
Operating margin-1853.92%-11.60%
Net margin-2258.89%-90.61%
ROE-663.38%-262.64%
ROIC-17.99%-21.42%

Growth (annualized)

MetricCBUSHCAT
Revenue CAGR (5Y)-34.28%6.24%
Total return CAGR (5Y)-59.70%-48.35%

Frequently asked

Which has grown faster, CBUS or HCAT?
Over the past five years, HCAT grew revenue faster — CBUS at a -34.28% CAGR versus HCAT at 6.24%.
How have CBUS and HCAT total returns compared?
Over the past 5 years, CBUS delivered -59.70% and HCAT delivered -48.35% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.